Filamentation modulates allosteric regulation of PRPS.
Huan-Huan HuGuang-Ming LuChia-Chun ChangYi-Lan LiJiale ZhongChen-Jun GuoXian ZhouBoqi YinTianyi ZhangJi-Long LiuPublished in: eLife (2022)
Phosphoribosyl pyrophosphate (PRPP) is a key intermediate in the biosynthesis of purine and pyrimidine nucleotides, histidine, tryptophan, and cofactors NAD and NADP. Abnormal regulation of PRPP synthase (PRPS) is associated with human disorders, including Arts syndrome, retinal dystrophy, and gouty arthritis. Recent studies have demonstrated that PRPS can form filamentous cytoophidia in eukaryotes. Here, we show that PRPS forms cytoophidia in prokaryotes both in vitro and in vivo. Moreover, we solve two distinct filament structures of E. coli PRPS at near-atomic resolution using Cryo-EM. The formation of the two types of filaments is controlled by the binding of different ligands. One filament type is resistant to allosteric inhibition. The structural comparison reveals conformational changes of a regulatory flexible loop, which may regulate the binding of the allosteric inhibitor and the substrate ATP. A noncanonical allosteric AMP/ADP binding site is identified to stabilize the conformation of the regulatory flexible loop. Our findings not only explore a new mechanism of PRPS regulation with structural basis, but also propose an additional layer of cell metabolism through PRPS filamentation.
Keyphrases
- small molecule
- structural basis
- transcription factor
- candida albicans
- endothelial cells
- rheumatoid arthritis
- molecular dynamics simulations
- escherichia coli
- single molecule
- dna binding
- single cell
- diabetic retinopathy
- bone marrow
- cell therapy
- binding protein
- case report
- mass spectrometry
- protein kinase
- amino acid
- solid state
- clinical evaluation
- cell wall